Ectopic Germinal Centers and IgG4-Producing Plasmacytes Observed in Synovia of HLA-B27+ Ankylosing Spondylitis Patients with Advanced Hip Involvement

por Feng, Xiugao, Xu, Xiangjin, Wang, Yue, Zheng, Zhiyong, Lin, Guiying
Publicado 2015

Risk of Death and Heart Failure among Patients with Type 2 Diabetes Treated by Metformin and Nonmetformin Monotherapy: A Real-World Study

por He, Siyao, Qian, Xin, Chen, Yanyan, Shen, Xiaoxia, Zhang, Bo, Chen, Xiaoping, Xu, Xiangjin, Li, Guangwei
Publicado 2021

Insulin delivery with a needle-free insulin injector versus a conventional insulin pen in Chinese patients with type 2 diabetes mellitus: A 16-week, multicenter, randomized clinica...

por Ji, Linong, Gao, Leili, Chen, Liming, Wang, Yangang, Ma, Zhongshu, Ran, Xingwu, Sun, Zilin, Xu, Xiangjin, Wang, Guixia, Guo, Lixin, Shan, Zhongyan
Publicado 2020

DUAL II China: Superior HbA1c reductions and weight loss with insulin degludec/liraglutide (IDegLira) versus insulin degludec in a randomized trial of Chinese people with type 2 di...

por Pei, Yu, Agner, Bue R., Luo, Bin, Dong, Xiaolin, Li, Dongmei, Liu, Jun, Liu, Lei, Liu, Ming, Lu, Yibing, Nishida, Tomoyuki, Xu, Xiangjin, Mu, Yiming
Publicado 2021

Efficacy and safety of lixisenatide in a predominantly Asian population with type 2 diabetes insufficiently controlled with basal insulin: The GetGoal‐L‐C randomized trial

por Yang, Wenying, Min, Kyungwan, Zhou, Zhiguang, Li, Ling, Xu, XiangJin, Zhu, Dalong, Venkateshwar Rao, A., Murthy, Laxminarayanappa Sreenivasa, Zhang, Nianxian, Li, Ivy, Niemoeller, Elisabeth, Shang, Shuhua
Publicado 2017

Efficacy and safety of insulin degludec/insulin aspart versus biphasic insulin aspart 30 in Chinese adults with type 2 diabetes: A phase III, open‐label, 2:1 randomized, treat‐to‐t...

por Yang, Wenying, Ma, Jianhua, Hong, Tianpei, Liu, Ming, Miao, Heng, Peng, Yongde, Wang, Changjiang, Xu, Xiangjin, Yang, Tao, Nielsen, Anne M., Pan, Lili, Liu, Weihong, Zhao, Weigang
Publicado 2019